Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical response

Smith et al.

  • Journal of Clinical Investigation
  • October 2019

Deletion of donor-reactive T cell clones after human liver transplant

Savage et al.

  • American Journal of Transplantation
  • September 2019

Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children

Whangbo et al.

  • Blood Advances
  • September 2019

Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients

Abraham et al.

  • Blood Advances
  • July 2019

CRISPR genome editing of murine hematopoietic stem cells to create Npm1-Alk causes ALK1 lymphoma after transplantation

Rajan et al.

  • Blood Advances
  • June 2019

T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant

Chapuis et al.

  • Nature Medicine
  • June 2019

Use of Highly Characterized EBV-Specific T Cells Outside of the Immediate Post-Transplant Setting

Rouce et al.

  • Cytotherapy
  • May 2019

Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease

Whangbo et al.

  • Blood Advances
  • April 2019

Graft γδ TCR Sequencing Identifies Public Clonotypes Associated with Hematopoietic Stem Cell Transplantation Efficacy in Acute Myeloid Leukemia Patients and Unravels Cytomegalovirus Impact on Repertoire Distribution

Arruda et al.

  • Journal of Immunology
  • March 2019